See also this year's filing and all EDGAR filings for this company.
PDF Report 0000881464_2011_Amylin_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000881464, Amylin Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 676,395,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 811,745,000 |
| 3 | remainder_Assets | 43,289,000 |
| 4 | LiabilitiesCurrent | 401,595,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 288,650,000 |
| 9 | ResearchAndDevelopmentExpense | 171,312,000 |
| 10 | remainder_Expenses | 363,862,000 |
| 11 | remainder_Revenues | 671,511,000 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,531,429,000 |
| 1 | Liabilities | 401,595,000 |
| 2 | Expenses | 823,824,000 |
| 3 | Revenues | 671,511,000 |
| 4 | StockholdersEquity | 1,129,834,000 |
| 5 | NetIncome | -152,313,000 |
| 6 | ComprehensiveNetIncome | -152,313,000 |
| 7 | BaseVar | 1,714,179,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.39 |
| 9 | EconomicCapitalRatio | 3.28 |
Edgar->Model Mapping
Feature Distribution
